Skip to main content

Table 1 Baseline characteristics of study participants

From: The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria

  Control pharmacy Intervention pharmacy Total (n = 1226) frequency/mean difference (95% CI) P value
n = 607 n = 619
Gender     
  -Female 328 (54.0%) 306 (49.4%) 634 (51.7%) 0.107
  -Male 279 (46.0%) 313 (50.6%) 592 (48.3%)
Age (years) 30.12 (10.23) 31.55 (11.46) 1.42 (0.20-2.64) 0.022
Age group     
  -Adolescent 65 (10.7%) 73 (11.8%) 138 (11.3%) 0.548
  -Adult 542 (89.3%) 546 (88.2%) 1088 (88.7%)  
Level of education (whole population)     
  -Primary or less 61 (10%) 57 (9.2%) 118 (9.6%) 0.618
  -At least secondary 546 (90%) 562 (90.8%) 1108 (90.4%)  
Level of income     
  -Less than average income 372 (61.3%) 370 (60.5%) 742 (60.5%) 0.588
  -Average income or more 235 (38.7%) 249 (40.2%) 484 (39.5%)  
Reported last treatment for malaria     
  -Less than 6 months ago 381 (62.8%) 386 (62.4%) 767 (62.6%) 0.882
  -More than 6 months ago 226 (37.2%) 233 (37.6%) 459 (37.4%)  
Who recommended anti-malarial     
  -Self 255 (42.0%) 303 (48.9%) 558 (45.5%) 0.015
  -Health professional 352 (58.0%) 316 (51.1%) 668 (54.5%)  
Participants with a doctor’s prescription prior to purchase of anti-malarial 169 (27.8%) 52 (8.4%)) 221 (18.0%) < 0.001
Reported positive lab test prior to purchase of anti-malarial 103 (17.0%) 96 (15.5%) 199 (16.2%) 0.488
History of fever in the last 48 hours 394 (64.9%) 166 (26.8%) 560 (45.7%) < 0.001